Drug Transporters. Группа авторов

toxicant handling by the OAT organic anion transporters in the kidney and other tissues. Nat Clin Pract Nephrol 2007; 3 (8):443–448.

      5 [5] Eraly SA, Monte JC, Nigam SK. Novel slc22 transporter homologs in fly, worm, and human clarify the phylogeny of organic anion and cation transporters. Physiol Genomics 2004; 18 (1):12–24.

      6 [6] Wu W, Baker ME, Eraly SA, Bush KT, Nigam SK. Analysis of a large cluster of SLC22 transporter genes, including novel USTs, reveals species‐specific amplification of subsets of family members. Physiol Genomics 2009; 38 (2):116–124.

      7 [7] Koepsell H. The SLC22 family with transporters of organic cations, anions and zwitterions. Mol Aspects Med 2013; 34 (2–3):413–435.

      8 [8] Hediger MA, Clemencon B, Burrier RE, Bruford EA. The ABCs of membrane transporters in health and disease (SLC series): introduction. Mol Aspects Med 2013; 34 (2–3):95–107.

      9 [9] Engelhart DC, Granados JC, Shi D, Saier Jr MH, Baker ME, Abagyan R, Nigam SK. Systems biology analysis reveals eight SLC22 transporter subgroups, including OATs, OCTs, and OCTNs. Int J Mol Sci 2020; 21 (5):1791.

      10 [10] Nigam SK, Bush KT, Martovetsky G, Ahn S‐Y, Liu HC, Richard E, Bhatnagar V, Wu W. The organic anion transporter (OAT) family: a systems biology perspective. Physiol Rev 2015; 95 (1):83–123.

      11 [11] Nigam SK, Bush KT, Bhatnagar V, Poloyac SM, MomperJD. The systems biology of drug metabolizing enzymes and transporters: relevance to quantitative systems pharmacology. Clin Pharmacol Ther 2020; 108 (1):40–53.

      12 [12] Zhang J, Wang H, Fan Y, Yu Z, You G. Regulation of organic anion transporters: role in physiology, pathophysiology, and drug elimination. Pharmacol Ther 2020; 217:107647.

      13 [13] Srimaroeng C, Perry JL, Pritchard JB. Physiology, structure, and regulation of the cloned organic anion transporters. Xenobiotica 2008; 38 (7–8):889–935.

      14 [14] Sun W, Wu RR, van Poelje PD, Erion MD. Isolation of a family of organic anion transporters from human liver and kidney. Biochem Biophys Res Commun 2001; 283 (2):417–422.

      15 [15] Shin HJ, Anzai N, Enomoto A, He X, Kim DK, Endou H, Kanai Y. Novel liver‐specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate. Hepatology 2007; 45 (4):1046–1055.

      16 [16] Schömig E, Spitzenberger F, Engelhardt M, Martel F, Ording N, Gründemann D. Molecular cloning and characterization of two novel transport proteins from rat kidney. FEBS Lett 1998; 425 (1):79–86.

      17 [17] Yokoyama H, Anzai N, Ljubojevic M, Ohtsu N, Sakata T, Miyazaki H, Nonoguchi H, Islam R, Onozato ML, Tojo A, Tomita K, Kanai Y, Igarashi T, Sabolic I, Endou H. Functional and immunochemical characterization of a novel organic anion transporter Oat8 (Slc22a9) in rat renal collecting duct. Cell Physiol Biochem 2008; 21 (4):269–278.

      18 [18] Tsuchida H, Anzai N, Shin HJ, Wempe MF, Jutabha P, Enomoto A, Cha SH, Satoh T, Ishida M, Sakurai H, Endou H. Identification of a novel organic anion transporter mediating carnitine transport in mouse liver and kidney. Cell Physiol Biochem 2010; 25 (4–5):511–522.

      19 [19] Nishiwaki T, Daigo Y, Tamari M, Fujii Y, Nakamura Y. Molecular cloning, mapping, and characterization of two novel human genes, ORCTL3 and ORCTL4, bearing homology to organic‐cation transporters. Cytogenet Cell Genet 1998; 83 (3–4):251–255.

      20 [20] Bahn A, Hagos Y, Reuter S, Balen D, Brzica H, Krick W, Burckhardt BC, Sabolic I, Burckhardt G. Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13). J Biol Chem 2008; 283 (24):16332–16341.

      21 [21] Mori K, Ogawa Y, Ebihara K, Aoki T, Tamura N, Sugawara A, Kuwahara T, Ozaki S, Mukoyama M, Tashiro K, Tanaka I, Nakao K. Kidney‐specific expression of a novel mouse organic cation transporter‐like protein. FEBS Lett 1997; 417 (3):371–374.

      22 [22] Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002; 417 (6887):447–452.

      23 [23] Burckhardt G, Burckhardt BC. in vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy. In: Fromm MF, Kim RB, editor. Drug Transporters. Berlin Heidelberg: Springer; 2011. p 29–104.

      24 [24] VanWert AL, Gionfriddo MR, Sweet DH. Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology. Biopharm Drug Dispos 2010; 31 (1):1–71.

      25 [25] Nigam SK. The SLC22 transporter family: a paradigm for the impact of drug transporters on metabolic pathways, signaling, and disease. Annu Rev Pharmacol Toxicol 2018; 58 (1):663–687.

      26 [26] Zhu C, Nigam KB, Date RC, Bush KT, Springer SA, Saier Jr MH, Wu W, Nigam SK. Evolutionary analysis and classification of OATs, OCTs, OCTNs, and other SLC22 transporters: structure‐function implications and analysis of sequence motifs. PLoS One 2015; 10 (11):e0140569.

      27 [27] Lee W, Ha J‐m, Sugiyama Y. Post‐translational regulation of the major drug transporters in the families of organic anion transporters and organic anion–transporting polypeptides. J Biol Chem 2020; 295 (50):17349–17364.

      28 [28] Simonson G, Vincent A, Roberg K, Huang Y, Iwanij V. Molecular cloning and characterization of a novel liver‐specific transport protein. J Cell Sci 1994; 107 (4):1065–1072.

      29 [29] Sekine T, Cha SH, Tsuda M, Apiwattanakul N, Nakajima N, Kanai Y, Endou H. Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett 1998; 429 (2):179–182.

      30 [30] Lopez‐Nieto CE. 1996. NKT cDNA sequence, GenBank Accession Number: MMU52842, submitted March 27, 1996.

      31 [31] Lopez‐Nieto CE, You G, Barros EJG, Beier DR, Nigam SK. Molecular cloning and characterization of a novel transport protein with very high expression in the kidney (Abstract). J Am Soc Nephrol 1996; 7:1301.

      32 [32] Lopez‐Nieto CE, You G, Bush K.T, Barros EJ, Beier DR, Nigam SK. Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. J Biol Chem 1997; 272 (10):6471–6478.

      33 [33] Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 1997; 272 (30):18526–18529.

      34 [34] Sweet DH, Wolff NA, Pritchard JB. Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney. J Biol Chem 1997; 272 (48):30088–30095.

      35 [35] Pavlova A, Sakurai H, Leclercq B, Beier DR, Yu AS, Nigam SK. Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct. Am J Physiol Renal Physiol 2000; 278 (4):F635–F643.

      36 [36] Ahn SY, Eraly SA, Tsigelny I, Nigam SK. Interaction of organic cations with organic anion transporters. J Biol Chem 2009; 284 (45):31422–31430.

      37 [37] Ahn SY, Jamshidi N, Mo ML, Wu W, Eraly SA, Dnyanmote A, Bush KT, Gallegos TF, Sweet DH, Palsson BO, Nigam SK. Linkage of organic anion transporter‐1 to metabolic pathways through integrated “omics”‐driven network and functional analysis. J Biol Chem 2011; 286 (36):31522–31531.

      38 [38] Vallon V, Eraly SA, Rao SR, Gerasimova M, Rose M, Nagle M, Anzai N, Smith T, Sharma K, Nigam SK, Rieg T. A role for the organic anion transporter OAT3 in renal creatinine secretion in mice. Am J Physiol Renal Physiol 2012; 302 (10):F1293–F1299.

      39 [39] Nigam AK, Li JG, Lall K, Shi D, Bush KT, Bhatnagar V, Abagyan R, Nigam SK. Unique metabolite preferences of the drug transporters OAT1 and OAT3 analyzed by machine learning. J Biol Chem 2020; 295 (7):1829–1842.

      40 [40] Brady KP, Dushkin H, Fornzler D, Koike T, Magner F, Her H, Gullans S, Segre GV, Green RM, Beier DR. A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse. Genomics 1999; 56 (3):254–261.

      41 [41] Kusuhara H, Sekine T, Utsunomiya‐Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kanai Y, Endou H. Molecular cloning